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Plaque Composition by Intravascular Ultrasound
and Distal Embolization After Percutaneous
Coronary Intervention
Bimmer E. Claessen, MD, PHD,*†‡ Akiko Maehara, MD,*† Martin Fahy, PHD,*†
e Xu, PHD,*† Gregg W. Stone, MD,*† Gary S. Mintz, MD*
New York, New York; and Amsterdam, the Netherlands
Distal embolization after percutaneous coronary intervention occurs in 15% to 70%of patients, depending on
the sensitivity of the diagnostic modality used, and is associated with a poor prognosis after elective and
primarypercutaneouscoronary intervention. Ithasbeenhypothesizedthat imagingof theplaquecomposition
can identify coronaryartery lesions that arepredisposed tocausingdistal embolization. This review report aims
to summarize all currently availablepublisheddataon theuseof assessment of atherosclerotic plaque compo-
sitionbyvirtual histology intravascularultrasound (VH-IVUS) to predict the occurrence of distal embolization.
A systematic review of the literature was performed. We searched Medline, ISI Web of Knowledge, and the
ochrane Library from January 2002 until March 2011. When a study was found to be relevant, the manu-
cript was obtained and reviewed. A total of 11 studies were identified investigating the relationship
etweenplaquecompositionassessedbyVH-IVUSanddistal embolization.Althoughall studiesused the same
quipment to perform and analyze VH-IVUS, there was considerable heterogeneity in patient characteristics,
utcome definitions, and reporting of VH-IVUS findings. Nevertheless, the necrotic core plaque component—
itherby itselforasaconstituentofaVHthincapfibroatheroma—wasassociatedwithdistal embolization inall
ut 2 of the 11 reviewed studies. Therefore, identification of lesions with large amounts of necrotic core on
H-IVUS could identify lesions thatmight benefit from the selective useof embolic protectiondevices. (J Am
oll Cardiol Img 2012;5:S111–8) © 2012 by the American College of Cardiology Foundation(
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tervention (PCI) is the result of vessel stretch-
ing and plaque dissection, redistribution,
r (especially in the unstable clinical setting)
mbolization into the distal microvasculature
eading to ischemia at the myocardial tissue level
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S112Plaque composition may be an important con-
tributing factor in the occurrence and extent of
distal embolization after PCI. Virtual histology
intravascular ultrasound (VH-IVUS) (Volcano
Corp., Rancho Cordova, California) is a widely
available technique allowing real-time determina-
tion of plaque composition in vivo using radiofre-
quency analysis of the backscattered ultrasound
signal. VH-IVUS can distinguish among 4 different
plaque components: fibrotic plaque, fibrofatty
plaque, necrotic core, and dense calcium. These are
represented as green, light green, red, and white,
respectively. Thus, VH-IVUS provides additional
information by offering an accurate assessment of
plaque composition on top of the 3-dimensional
anatomical assessment provided by grayscale
IVUS (6,7). We performed a systematic
review of all currently available data on the
ability of plaque composition by VH-IVUS
to predict distal embolization after PCI.
Study Search Strategy
We searched Medline, ISI Web of Knowl-
edge, and the Cochrane Library with var-
ious combinations of the terms “virtual
histology,” “intravascular ultrasound,”
“embolization,” “no-reflow,” “infarction,”
“microvascular,” “obstruction,” and/or “in-
jury” in the abstract and/or title. Articles
eligible for further review were selected
after screening abstracts and titles. We
searched the aforementioned data sources
for possible studies from January 2002
until March 2011. The starting date of
2002 was chosen because the first clinical
case with VH-IVUS was performed in
that year. When a study was found to be
relevant, the manuscript was obtained and
reviewed; and the references were searched for
relevant articles. Figure 1 shows a flowchart of the
study search strategy. A total of 11 studies were
identified that described the relationship between
plaque composition assessed by VH-IVUS and
distal embolization assessed by a variety of tech-
niques and definitions both in stable and unstable
patients (Table 1).
Literature Review
Table 1 summarizes all studies included in this
systematic review (8–18). The necrotic core plaque
ent
y
ioncomponent either by itself or as a constituent of a ivirtual histology-thin cap fibroatheroma (VH-
TCFA) was associated with distal embolization
in all but 2 of the 11 reviewed studies. Figure 2
summarizes the various quantitative measurements
of necrotic core plaque in the studies included in
this systematic review (8,10,12–17). Studies by
Kawamoto et al. (9), Bose et al. (11), and Yamada
et al. (18) were not included in this figure, as they
did not use a dichotomous definition of distal
embolization.
Kawaguchi et al. (8) and Kawamoto et al. (9)
were the first to investigate the relationship between
VH-IVUS plaque characteristics and the occur-
rence of distal embolization. Kawaguchi et al. (8)
performed VH-IVUS in a cohort of 71 patients
with ST-segment elevation myocardial infarction
(STEMI). Thrombus aspiration was performed in
all patients before VH-IVUS imaging was per-
formed, and stents were implanted in all patients
immediately after VH-IVUS. The primary end-
point of ST-segment re-elevation occurred in 11
patients (15.5%). Receiver-operating characteristic
curve analysis showed a strong association between
necrotic core volume and ST-segment re-elevation.
A cutoff value of 33.4 mm3 predicted ST-segment
e-elevation with a sensitivity of 81.7% and a
pecificity of 63.6%. Total plaque volume was not
ssociated with an increased risk of distal emboli-
ation in this study.
In a study of 44 patients, Kawamoto et al. (9)
nvestigated the relationship between pre-intervention
H-IVUS assessed plaque characteristics and small
mbolic particles detected using a Doppler guidewire
uring elective stent implantation. Patients were di-
ided into tertiles according to the number of
igh-intensity transient signals (HITS) detected
y the Doppler guidewire. In this relatively small
tudy, necrotic core area was identified as an
ndependent predictor of the tertile with the
reatest number of HITS after multivariate lo-
istic regression. Moreover, there was a signifi-
ant negative correlation between the number of
ITS and coronary flow velocity reserve imme-
iately after stenting.
After these initial observations, a number of
ther research groups published results of similar
tudies (10–18). Studies by Nakamura et al. (15)
nd Bae et al. (10) in cohorts of 50 STEMI patients
nd 57 acute coronary syndrome (ACS) patients,
espectively, did not find a relationship between
ecrotic core and distal embolization. Nakamura et
l. (15) reported that the presence of a “marblelike”A B B R E V I A T I O N S
A N D A C R O N YM S
ACS acute coronary
syndrome(s)
CK creatine kinase
CK-MB creatine kinase-
myocardial band
cTnI cardiac troponin I
HITS high-intensity transi
signals
OCT optical coherence
tomography
OR odds ratio
PCI percutaneous coronar
intervention
STEMI ST-segment elevat
myocardial infarction
TIMI Thrombolysis In
Myocardial Infarction
VH-IVUS virtual histology
intravascular ultrasound
VH-TCFA virtual histologymage, consisting of fibrofatty and fibrous plaque,
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S113was associated with angiographic no-reflow (p 
0.02). It should be noted that VH-IVUS analysis of
the percentage of necrotic core can be compromised
by the presence of thrombus; thrombus has a
VH-IVUS appearance of fibrotic or fibrofatty
plaque depending on its age (19). For example, in
the study by Nakamura et al. (15) in STEMI
patients, the marblelike image may represent a
mixed red and white thrombus to explain the
relationship between the VH-IVUS appearance and
angiographic no-reflow.
A large number of other publications did find a
relationship between necrotic core and distal em-
bolization. For example, Higashikuni et al. (12)
performed VH-IVUS measurements in 47 patients
with ACS (acute myocardial infarction or unstable
angina) preceded by thrombus aspiration if throm-
bus was detected angiographically or by IVUS
before stent implantation. In 9 patients (18.4%)
with no-reflow (defined as a decrease in Thrombol-
ysis In Myocardial Infarction [TIMI] flow grade
after mechanical dilation compared with before),
the percentage of necrotic core at the minimal
lumen area site was significantly increased com-
pared with patients without no-reflow (22.3 
11.0% vs. 11.8  0.3%, p  0.01). Similarly, in an
analysis of the entire culprit lesion, patients with
no-reflow had a larger percentage of necrotic core
volume (22.1  9.3% vs. 11.7  7.9%, p  0.01)
and a smaller percentage of fibrotic plaque volume
(59.6  11.2% vs. 68.3  10.2%, p  0.03).
Bose et al. (11) performed VH-IVUS before
stent implantation in 55 patients who underwent
elective PCI for a single de novo coronary artery
lesion. Serum creatine kinase (CK) and cardiac
troponin I (cTnI) were measured before PCI and at
6, 12, and 24 h after PCI. Strong correlations
between different measurements of necrotic core
(necrotic core volume, necrotic core volume per
10-mm-long lesion segment, and percentage ne-
crotic core volume) and the maximum increase in
cardiac biomarkers were observed (r  0.64, 0.66,
and 0.52, respectively; all p  0.01).
The largest investigation to date of plaque com-
position and no-reflow was performed in a cohort
of 190 consecutive ACS patients by Hong et al.
(13). This study group also investigated the pres-
ence of the VH-TCFA phenotype (defined as
necrotic core 10% of plaque area in at least 3
consecutive frames without overlying fibrous tissue
in the presence of 40% plaque burden) (20).
No-reflow, defined as TIMI flow grade 2 after
stenting, occurred in 12.6% of patients. Patientswith no-reflow had a significantly greater absolute
and percentage necrotic core area at the minimum
lumen area site (16.2  1.2 mm2 vs. 0.9  0.8
mm2, p  0.01, and 24.5  14.3% vs. 16.1 
10.6%, p  0.01). Absolute necrotic core volume
and percentage necrotic core volume were also
larger in patients with no-reflow (30  24 mm3 vs.
16  17 mm3, p  0.01; and 22  11% vs. 14 
%, p  0.01). After multivariable analysis, the
ercentage necrotic core volume remained an
ndependent predictor of no-reflow (odds ratio
OR]: 1.13, p  0.01). Moreover, at least 1
H-TCFA, as well as multiple VH-TCFA, were
ignificantly more common in patients with no-
eflow (71% vs. 36%, p  0.01, for at least 1
H-TCFA and 38% vs. 15%, p 0.01, for
multiple VH-TCFA). Other studies by Ohshima
et al. (16) and Yamada et al. (18) also reported
that lesions containing a VH-TCFA are more
likely to cause distal embolization after PCI
(16,18).
Another publication by Hong et al. (14), but
with a different cohort of patients studied at a
different institution at a different time, investi-
gated the impact of plaque composition on car-
diac cTnI release after PCI. The results from this
study of 80 patients (29 with stable angina, 51
Figure 1. Flow Chart of Study Search Strategy
A total of 11 studies were identiﬁed that described the relationship
between plaque composition assessed by virtual histology-intravasc
ultrasound and distal embolization.s
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S114confirmed and extended their previous observa-
tions. Post-PCI cTnI elevation 3 the upper
limit of normal was present in 38 patients (47%).
Absolute and percentage necrotic core volumes
and absolute and percentage necrotic core area at
the minimum lumen site and at the largest
necrotic core site were significantly greater in
patients with post-PCI cTnI elevation 3 the
upper limit of normal (n  38, 47%) than in
patients without post-PCI cTnI elevation 3
the upper limit of normal. After multivariable
analysis, absolute necrotic core area at the mini-
mum lumen site remained an independent pre-
dictor of post-PCI cTnI elevation 3 the
upper limit of normal (OR: 1.32, p  0.01).
Finally, in a recent study by Shin et al. (17)
reported an association between area, percentage
area, and volume of necrotic core and creatine
kinase-myocardial band (CK-MB) elevation of
1 upper limit of normal in a cohort of 112
consecutive patients with unstable angina. After
multivariate analysis, dense calcium volume and
percentage necrotic core were the only indepen-
dent predictors of post-PCI CK-MB elevation.
Plaque Composition Using Other
ImagingModalities and Distal Embolization
Studies using different image modalities such as
integrated backscatter IVUS, near-infrared spec-
troscopy, and optical coherence tomography (OCT)
have also reported an association between necrotic
Studies Investigating Plaque Characteristics by VH-IVUS and Dis
Year N
Elective/ACS/
STEMI
Pre-Stent
Thrombectomy Prima
2007 71 STEMI Yes, 100% ST-segment re
2007 44 Elective No High-intensity
2007 50 STEMI Yes, 75% Decrease in T
2008 57 ACS Yes, 14% TIMI ﬂow grad
2008 49 ACS Yes, 67% Decrease in T
2008 55 Elective No CK/cTnI eleva
2011 190 ACS No TIMI ﬂow grad
2009 80 Elective and ACS No cTnI 3 ULN
2009 44 STEMI Yes, 100% TIMI ﬂow grad
2010 29 Elective No Index of micro
2011 112 Unstable angina No CK-MB elevati
brofatty plaque and NC volumes and ﬁbrofatty plaque and percentage NC volu
drome(s); CK  creatine kinase; cTnI  cardiac troponin I; IVUS  intravascular ul
cardial infarction, TIMI  Thrombolysis In Myocardial Infarction; TCFA  thin-capcore and distal embolization (21–23). Uetani et al. o(23) performed integrated backscatter IVUS mea-
surements in 114 patients undergoing elective
PCI. By receiver-operating characteristic analy-
sis, they identified a cutoff of 45.6 mm3 of lipid
olume as a predictor of myocardial injury de-
ned as a post-procedural rise in troponin T
3 the upper limit of normal (23). Yonetsu et
l. (22) performed OCT measurements in 125
onsecutive patients undergoing PCI. After mul-
ivariate analysis, the presence of OCT-TCFA
defined as a lipid-rich plaque with a fibrous cap
hickness 70 m) was an independent predictor
f a post-procedural rise in CK-MB 3 the
pper limit of normal (OR: 4.68, p  0.01) (22).
A study by Tanaka et al. (24) showed that
OCT-derived lipid arc can predict no-reflow
after PCI in patients with non–STEMI. As
compared with VH-IVUS, OCT offers the ad-
vantage of a higher resolution (10 m com-
pared with 100 m for IVUS), which enables
maging of coronary endothelium and thin fi-
rous caps. Moreover, IVUS is not a reliable
echnique to image thrombus, whereas OCT is.
his also holds true for mural thrombi, which are
ot only found in unstable but also stable angina
ectoris patients. On the other hand, OCT has
elatively poor penetration through tissue and
lood, which limits the ability of OCT to evalu-
te the extent of coronary plaque volume. Also,
here are conflicting reports concerning the accu-
acy of OCT to classify plaque composition
25,26).
Recently, Goldstein et al. (21) described 4 cases
mbolization
utcome
NC Associated With Distal Embolization
NC
Volume
% NC
Volume
NC
Area
% NC
Area VH-TCFA
vation  n/a n/a n/a n/a
sient signals n/a n/a  n/a n/a
ow grade n/a – n/a n/a n/a
2 – n/a n/a – n/a
ow grade n/a  n/a  n/a
3 ULN   n/a n/a n/a
2     
    n/a
2 –* –* n/a n/a 
cular resistance n/a n/a n/a n/a 
ULN  n/a   n/a
were associated with distal embolization.
und; MB  myocardial band; n/a  not available; NC  necrotic core; STEMI 
oatheroma(s); ULN  upper limit of normal; VH  virtual histology.Table 1. Summary of tal E
First Author (Ref. #) ry O
Kawaguchi et al. (8) -ele
Kawamoto et al. (9) tran
Nakamura et al. (15) IMI ﬂ
Bae et al. (10) e 
Higashikuni et al. (12) IMI ﬂ
Bose et al. (11) tion
Hong et al. (13) e 
Hong et al. (14)
Ohshima et al. (16) e 
Yamada et al. (18) vas
Shin et al. (17) on 
*However, summation of ﬁ mes
ACS  acute coronary syn trasof distal embolization after balloon dilation of
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S115lipid-rich plaques detected by the novel imaging
technique of near-infrared spectroscopy. Near-
infrared spectroscopy illuminates tissue with near-
infrared light with a wavelength between 780 and
2,500 nm. As different types of chemical bonds
absorb light with differing wavelengths, the result-
ing absorbance spectrum reflects the chemical
makeup of the imaged tissue. As a result, this
technique is very effective in detecting lipid-laden
Figure 2. Measurements of NC Plaque Components in Patients
Studies by Kawamoto et al. (9), Bose et al. (11), and Yamada et al. (
dichotomous deﬁnition of distal embolization. NC  necrotic core.plaque (27,28). The device used in the study byGoldstein et al. (21) combines the near-infrared
spectroscopy lipid plaque detection technology with
grayscale IVUS.
Clinical Implications
There seems to be an important relationship
between the necrotic core plaque component
assessed using VH-IVUS or other imaging mo-
and Without Distal Embolization
were not included in this ﬁgure as they did not use aWith
18)dalities and the occurrence of distal embolization.
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S116Figure 2 shows that the extent of necrotic core
was larger in patients with distal embolization
regardless of whether it was reported as volume,
percentage volume, area, or percentage area. Fur-
thermore, 3 studies reported that VH-TCFA,
which contain a large amount of necrotic core,
were more common in patients with distal em-
bolization (13,16,18). Pathologists have postu-
lated TCFA to be the precursor lesion of plaque
rupture, although a recent trial showed that only
a minority of VH-TCFA cause cardiovascular
events (29 –33). The VH-IVUS diagnosis of a
TCFA must be inferred because pathologists
have defined a TCFA as a necrotic core with an
overlying fibrous cap measuring 65 m, less
than the resolution of IVUS (33).
Thus, lesions containing large lipid-rich ne-
crotic cores are predisposed to iatrogenic distal
embolization. The use of pre-intervention statins,
vasodilators, or embolic protection devices could
be particularly suited for these high– embolic-risk
patients. Although the concept of embolic pro-
tection seems especially appealing, distal and
proximal embolic protection devices have failed
to show a treatment benefit in several randomized
clinical trials in native coronary artery lesions not
stratified by their composition, even in patients
with ACS (34 –36). Prior trials examining em-
bolic protection devices have shown clinical ben-
efit only in situations where the amount of debris
is largest, such as in saphenous vein grafts. To the
best of our knowledge, no trial has yet been pub-
lished or presented investigating pre-procedural
lesion assessment to guide the decision whether
or not to randomize a patient. The randomized
CANARY (Coronary Assessment by Near-Infrared
of Atherosclerotic Rupture-Prone Yellow) trial
will investigate whether a distal protection device
can reduce distal embolization in patients with
lesions containing a large lipid core plaque as
assessed by near-infrared spectroscopy. The cur-
rent review indicates that a similar trial using
VH-IVUS to risk-stratify lesions prior to stent
implantation might be warranted.
Several factors complicate direct interstudy
comparisons in this review. Although all studies
used the same equipment to perform and analyze
VH-IVUS, there was considerable heterogeneitybectomy, outcome definitions, and reporting of
VH-IVUS findings (Table 1). Six studies en-
rolled only ACS patients, 3 studies enrolled only
elective patients, and 1 study enrolled both. As
there is no consensus on how to measure distal
embolization, outcome definitions included inva-
sive measurement of embolizing particles by Doppler
guidewire, measurement of index of microvascular
resistance, ST-segment re-elevation, measurements of
TIMI flow, and cardiac biomarkers. These end-
points were all surrogates for distal embolization
of atherosclerotic plaque material after PCI.
However, although distal embolization was defi-
nitely a contributing factor in the aforementioned
endpoints, it may not have been the sole contrib-
uting factor. For example, acute obstruction of
blood flow to the distal vasculature has also been
shown to cause capillary damage resulting in slow
flow, especially in ACS patients (37). Finally,
VH-IVUS measurements were not reported uni-
formly in the reviewed studies. A consensus
document published in 2009 recommended re-
porting absolute and relative VH-IVUS parame-
ters (fibrofatty plaque, fibrotic plaque, necrotic
core, and dense calcium) at the site of minimum
lumen area as well as averaged over the entire
lesion (20). However, most studies were per-
formed prior to publication of the consensus
document, and only 2 studies reported VH-IVUS
findings in the recommended manner (13,14).
Conclusions
Observational studies show a clear relationship
between the amount of necrotic core and distal
embolization on VH-IVUS imaging and alterna-
tive imaging modalities (integrated backscatter
IVUS, OCT, near-infrared spectroscopy). The
results of randomized trials will have to be
awaited to determine whether imaging of plaque
composition in combination with adjunctive
pharmacological or device-based interventions
reduces the incidence of distal embolization.
Reprint requests and correspondence: Dr. Gary S. Mintz,
Cardiovascular Research Foundation, 111 East 59th
Street, 11th Floor, New York, New York 10022. E-mail:in patient characteristics, use of pre-stent throm- gmintz@crf.org.
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